Previous 10 | Next 10 |
Inogen, Inc. (NASDAQ: INGN ), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that the Company’s management will be participating in the 17 th Annual Morgan Stanley Global Healthcare Conference in New York. ...
Inogen (NASDAQ: INGN) and Abiomed (NASDAQ: ABMD) are innovative medical device companies that have put up impressive growth numbers in recent years. However, they both failed to meet Wall Street's expectations for their second-quarter earnings results and cut full-year guidance in respon...
On this week's episode of Industry Focus: Healthcare , host Shannon Jones and Motley Fool contributor Brian Feroldi catch listeners up on four companies we've talked about before: Abiomed (NASDAQ: ABMD) , Inogen (NASDAQ: INGN) , Guardant Health (NASDAQ: GH) , and Shoc...
Inogen ( INGN ) has seen the share price implosion continue in recent weeks and months, while this was of the market's darlings last year. While momentum seen last year was clearly not sustainable, the question is if the situation has reversed to the other side. The company has seen solid ...
Actinium Pharmaceuticals (NYSEMKT: ATNM ) initiated with Outperform rating at William Blair. Shares up 9% premarket. More news on: Actinium Pharmaceuticals, Inc., Omega Healthcare Investors, Inc., Inogen, Inc., Healthcare stocks news, Stocks on the move, , Read more ...
Inogen, Inc. (INGN) Q2 2019 Earnings Conference Call August 7, 2019 08:30 a.m. ET Company Representatives Scott Wilkinson - Chief Executive Officer Ali Bauerlein - Chief Financial Officer & Co-Founder Matt Bacso - Investor Relations Manager Conference Call Participants ...
The following slide deck was published by Inogen, Inc. in conjunction with their 2019 Q2 earnings Read more ...
DPW Holdings (NYSEMKT: DPW ) -30% on announcing stock offering. More news on: DPW Holdings, Inc., New Relic, Inc., Oasis Petroleum Inc., Stocks on the move, Read more ...
Inogen ( INGN ) Q2 results : Revenues: $101.1M (+4.0%); Sales: $95.9M (+4.2%); direct-to-consumer domestic sales: $5.2M (-1.9%). More news on: Inogen, Inc., Healthcare stocks news, Earnings news and commentary, Stocks on the move, Read more ...
Inogen (NASDAQ: INGN ): Q2 GAAP EPS of $0.45 misses by $0.04 . More news on: Inogen, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...
News, Short Squeeze, Breakout and More Instantly...
Inogen, Inc. (Nasdaq: INGN ), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that it will report second quarter 2024 financial results after the market closes on Tuesday, August 6, 2024. On the same day, the Company wil...
Inogen, Inc. (Nasdaq: INGN ), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced the appointment of Kevin P. Smith as General Counsel and Executive Vice President, Business Development, effective July 22, 2024. Mr. Smith jo...